1-3 of 3
Paolo Prontera
Close
Sort by
Journal Articles

2p15-p16.1 microdeletions encompassing and proximal to BCL11A are associated with elevated HbF in addition to neurologic impairment

Brief Report
Alister P. W. Funnell, Paolo Prontera, Valentina Ottaviani, Maria Piccione, Antonino Giambona, Aurelio Maggio, Fiorella Ciaffoni, Sandra Stehling-Sun, Manuela Marra, Francesca Masiello, Lilian Varricchio, John A. Stamatoyannopoulos, Anna R. Migliaccio, Thalia Papayannopoulou
Journal: Blood
Blood (2015) 126 (1): 89–93.
https://doi.org/10.1182/blood-2015-04-638528
Published: 2015
Includes: Supplemental data
Journal Articles

Patterns of Clonal Evolution in Ph’-Positive Chronic Myelogenous Leukemia (CML) during Chronic Phase: Overall Incidence, Type, Multiplicity, Development Time, Effect on Subsequent Genetic Instability, Sokal Risk, Type of bcr/abl Transcript and Hematological Evolution.

Debora Luzi, Lorenzo Falchi, Rita Emili, Ilaria Angeletti, Paolo Prontera, Giovanna Venti, Alessandra Bassetti, Marta Gubbiotti, Vincenzo Capparella, Erminia Gentileschi, Emilio Donti, Anna Marina Liberati
Journal: Blood
Blood (2006) 108 (11): 4802.
https://doi.org/10.1182/blood.V108.11.4802.4802
Published: 2006
Journal Articles

Philadelphia Chromosome (Ph’) Secondary Clones in Chronic Myeloid Leukemia (CML) Are Not Indicative of Resistance to IFNa- or Imatinib-Based Treatment Regimens.

Lorenzo Falchi, Paolo Prontera, Debora Luzi, Viola Festuccia, Rita Emili, Enrico Gottardi, Emilio Donti, Anna Marina Liberati
Journal: Blood
Blood (2006) 108 (11): 4806.
https://doi.org/10.1182/blood.V108.11.4806.4806
Published: 2006